Percutaneous Coronary Intervention Devices Market – Monitoring Growth Opportunities 2026

21/set/2020 09:44:20 Polaris Market Research Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion by 2027 according to a new study by Polaris Market Research. Coronary artery disease (CAD) is causing most of deaths globally. The factors contributing to the disease include sedentary lifestyle, smoking, obesity, hereditary factors and alcohol usage. The mortality rate of CAD has been tremendously increasing grabbing the attention for researchers and clinicians globally, With the technological advancements in stent technologies, design of the guide wires, advent of next generation  coronary catheters (percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA) balloon catheters ), and the availability of coronary guide wires (steel based, nitinol based ) increased the treatment scope of the coronary heart diseases.

 

Polaris Market research has segmented the percutaneous coronary intervention (PCI) devices market report on the basis of product, end-use and region

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-sample

 

The emergence of dedicated catheterization labs in high income countries is also pivotal factor influencing the growth of the PCI devices market. The next generation Cath labs offers advanced services and performs interventional therapeutic procedures such as PCI, PTCA, epicardial ablations of ventricular tachycardia, aortic valve replacements and mitral valve repairs. Additionally, they also perform interventional cardiac electrophysiological procedures, pacemaker implantation and cardiac defibrillator implantation. The number of PCI procedures and other cardiac interventions is substantially increasing with the increase in the cardiovascular diseases globally.

 

To increase the performance of multi-specialty hospitals, many government and private hospitals are setting up catheterization labs for improved service offerings. This concept is gaining popularity for PCI procedures in Canada, the US, the UK, Germany, and other western countries. The factors favoring its growth include the conversion of physician’s office to alternate hospital providers, surgeons’ relationship with the manufacturers to eliminate the need of general practitioner officers (GPO), and the expansion of services provided by the hospitals.

 

Get Exclusive Discount on This Report : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-discount-pricing

 

 

Market participants such as Abbott, B. Braun, ASAHI INTECC Company Limited, Biosensors International Group, Ltd, Boston Scientific Corporation, C. R. Bard, BIOTRONIK, Comed BV, Cook, Meril Lifesciences, Cordis, Medtronic PLC, Merit Medical System, and Terumo Corporation are some of the key players operating in the percutaneous coronary intervention (PCI) devices market. Key vendors are investing huge amounts into their R&D and introducing new technologies and launching new products to stay competitive in this market. Several products were launched in the recent past with the latest next generation technology which caters the growing needs of the physician and the patients.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl